Dosing rationale using population pharmacokinetics of sotalol in children with tachycardia

被引：0
|
作者：
Läer, S
Elshoff, JP
Mir, TS
Müller-Wolf, C
Weil, J
Hulpke-Wette, M
Meibohm, B
机构：
[1] Univ Hamburg, Hosp Eppendorf, Inst Expt & Klin Pharmakol, D-20246 Hamburg, Germany
[2] Univ Hamburg, Hosp Eppendorf, Abt Padiat Kardiol, D-20246 Hamburg, Germany
[3] Univ Gottingen, Abt Padiat Kardiol, D-3400 Gottingen, Germany
[4] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2003年 / 367卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
441
引用
收藏
页码：R114 / R114
页数：1
相关论文
共 50 条
  • [1] Population pharmacokinetics and pharmacodynamics of sotalol in infants and children with tachycardia.
    Meibohm, B
    Zhang, W
    Elshoff, J
    Behn, F
    Hulpke-Wette, M
    Läer, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P71 - P71
  • [2] Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia
    Laër, S
    Elshoff, JP
    Meibohm, B
    Weil, J
    Mir, TS
    Zhang, WH
    Hulpke-Wette, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (07) : 1322 - 1330
  • [3] Pharmacokinetics of sotalol in children with supraventricular tachycardia.
    Läer, S
    Behn, F
    Wauer, I
    Hulpke-Wette, M
    Mir, TS
    Meibohm, B
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 130 - 130
  • [4] Termination of automatic atrial tachycardia in an infant by adequate sotalol dosing -: Indication of clinically relevant age-dependent pharmacokinetics of sotalol
    Läer, S
    Meibohm, B
    Mir, TS
    Hulpke-Wette, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (02) : 181 - 182
  • [5] Body weight and age for individually adjusted a priori sotalol dosing in children with supraventricular tachycardia
    Laer, S
    Elshoff, JP
    Mir, TS
    Hulpke-Wette, M
    Weil, J
    CIRCULATION, 2003, 108 (17) : 465 - 465
  • [6] Population Pharmacokinetics and Dosing of Ethionamide in Children with Tuberculosis
    Nyberg, Henrik Bjugard
    Draper, Heather R.
    Garcia-Prats, Anthony J.
    Thee, Stephanie
    Bekker, Adrie
    Zar, Heather J.
    Hooker, Andrew C.
    Schaaf, H. Simon
    McIlleron, Helen
    Hesseling, Anneke C.
    Denti, Paolo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
  • [7] Treatment of fetal tachycardia with sotalol: Transplacental pharmacokinetics and pharmacodynamics
    Oudijk, MA
    Ruskamp, JM
    Ververs, FFT
    Ambachtsheer, EB
    Stoutenbeek, P
    Visser, GHA
    Meijboom, EJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (04) : 765 - 770
  • [8] Population Pharmacokinetics of Bevacizumab in Children with Osteosarcoma: Implications for Dosing
    Turner, David C.
    Navid, Fariba
    Daw, Najat C.
    Mao, Shenghua
    Wu, Jianrong
    Santana, Victor M.
    Neel, Michael
    Rao, Bhaskar
    Willert, Jennifer Reikes
    Loeb, David M.
    Harstead, K. Elaine
    Throm, Stacy L.
    Freeman, Burgess B., III
    Stewart, Clinton F.
    CLINICAL CANCER RESEARCH, 2014, 20 (10) : 2783 - 2792
  • [9] Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy
    Chhun, Stephanie
    Jullien, Vincent
    Rey, Elisabeth
    Dulac, Olivier
    Chiron, Catherine
    Pons, Gerard
    EPILEPSIA, 2009, 50 (05) : 1150 - 1157
  • [10] Population pharmacokinetics (PK) of sotalol (S).
    Shi, J
    Hinderling, PH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P66 - P66
12345